Visionary Holdings Inc. Announces Unaudited Interim Financial Results for the Six Months Ended September 30, 2025

Visionary Holdings (NASDAQ:GV)

NY, UNITED STATES, August 9, 2026 /EINPresswire.com/ -- Toronto, Ontario, Canada – August 10, 2026 – Visionary Holdings Inc. (NASDAQ Capital Market, File No. 001-41385) ("Visionary," the "Company," or "Visionary Holdings") today announced its unaudited consolidated interim financial results for the six-month period from April 1, 2025 to September 30, 2025.
I. Report Information
1. Reporting Period: April 1, 2025 through September 30, 2025 (six-month interim period). All financial information is presented in U.S. dollars and has not been audited by the Company's independent registered public accounting firm.
2. SEC Filing: Form 6-K, including:
• Exhibit 99.1: Unaudited Interim Consolidated Balance Sheets and Consolidated Statements of Comprehensive Loss;
• Exhibit 99.2: Management's Discussion and Analysis (MD&A);
3. Authorized Signatory: The Form 6-K was executed and submitted by Chief Executive Officer Xiyong Hou on August 3, 2026.
II. Financial and Operating Highlights
(Compared with the six months ended September 30, 2024)
(A) Significant Revenue Mix Shift; Total Revenue Decreased 87.0%
Total revenue for the period was $434,648, compared with $3,347,238 in the prior-year period, representing a decrease of $2,912,590.
(B) Gross Profit Declined While Gross Margin Improved Significantly
Total gross profit was $283,961, a decrease of 66.8% from the prior-year period.
(C) Operating Expenses Reduced Overall; Administrative Expenses Increased
Total operating expenses were $487,057, representing a 52.5% year-over-year decrease.
(D) Net Loss Narrowed Significantly
(E) Financial Position (As of September 30, 2025)
Total assets were $65,653,914, representing a slight increase from March 31, 2025.
Total liabilities were $62,258,550, consisting primarily of short-term mortgages and bank borrowings. Approximately $47.07 million of bank mortgage debt was due within one year, resulting in significant short-term liquidity pressure.
Total shareholders' equity was $3,395,364, reflecting a decline from the previous fiscal year-end due to continuing accumulated operating deficits.
Cash and cash equivalents totaled $132,125, indicating limited liquidity reserves.
III. Strategic Development and Business Progress
In response to changing Canadian international student policies, the Company has initiated a strategic transformation with biotechnology as its primary growth platform.
• Biotechnology,
• Health and Wellness
IV. Significant Corporate Developments
(A) Court-Appointed Receivership of Core Properties
On August 27, 2024, the Ontario Superior Court of Justice (Commercial List), upon application by Bank of China (Canada), appointed Ernst & Young Inc. as receiver over the assets of the Company's wholly owned subsidiary, 13995291 Canada Inc., including two Toronto office properties.
The Company appealed the appointment. In February 2025, the Court authorized the receiver to market and sell the properties while granting the Company a 19-week redemption period.
As a result, rental operations were completely discontinued, and the associated mortgage debt was fully satisfied through the disposition process.
(B) Financing Transactions
• On October 2, 2024, the Company entered into a US$6 million Senior Secured Convertible Note Agreement, issuing an initial US$1 million convertible note maturing on October 2, 2025, which remained outstanding as of the date of this report.
• In January 2025, an additional US$1.5 million convertible note was issued at an original issue discount of 10%, maturing January 31, 2026, with a contractual 9.99% beneficial ownership limitation upon conversion.
• On December 31, 2024, the Company entered into a private placement agreement to issue 21 million common shares at US$1.00 per share, for gross proceeds of US$21 million. Regulatory approvals remain pending, and the transaction has not yet closed.
(C) Acquisitions and Joint Ventures
Smarco Building Solutions Inc., Goldmine Technology Finance Group Inc., American Precision Biotech Inc.
V. Management Commentary
Chief Executive Officer Xiyong Hou commented: "The first half of 2025 represented a critical transition period as we reshaped the Company's business portfolio. Although the court-supervised disposition of our Toronto properties reduced rental revenue to zero, we successfully narrowed our losses by significantly reducing discretionary professional service expenses and improving labor efficiency within our education operations. We also experienced a meaningful improvement in operating cash flow.
VI. Exhibits
• Exhibit 99.1: Unaudited Consolidated Interim Financial Statements for the Six Months Ended September 30, 2025 (Balance Sheets and Statements of Comprehensive Loss)
• Exhibit 99.2: Management's Discussion and Analysis of Unaudited Financial Statements (MD&A)

Investor Relations
Email: ir@visionary.holdings
445 Apple Creek Blvd., Unit 217
Markham, Ontario L3R 9X7 Canada
Telephone: +1 (905) 305-1881
Website: https://visionary.holdings

GV
Visionary Holdings Inc.
email us here